summary
Introduced
06/12/2019
06/12/2019
In Committee
06/13/2019
06/13/2019
Crossed Over
Passed
Dead
12/31/2020
12/31/2020
Introduced Session
116th Congress
Bill Summary
To require the Comptroller General of the United States to study the role pharmacy benefit managers play in the pharmaceutical supply chain and to provide Congress with appropriate policy recommendations, and for other purposes. This bill requires the Government Accountability Office to study the role of pharmacy benefit managers (PBMs) with respect to federally facilitated exchanges, including the role of PBMs in pharmaceutical supply chains, the competition among PBMs, and the use of rebates and fees by PBMs in such exchanges.
AI Summary
This bill requires the Government Accountability Office (GAO) to conduct a study on the role of pharmacy benefit managers (PBMs) in the pharmaceutical supply chain for federally facilitated health insurance exchanges. The study will examine various aspects of PBMs' activities, such as their role in the supply chain, the level of competition among PBMs, the use of rebates and fees, the impact on drug formularies, and the extent of the difference between what PBMs charge private payers and what they pay pharmacies. The GAO will then submit a report with the study results and policy recommendations to the relevant congressional committees and the Secretary of Health and Human Services.
Committee Categories
Business and Industry, Health and Social Services
Sponsors (5)
Last Action
Referred to the Subcommittee on Health. (on 06/13/2019)
Official Document
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
| Document Type | Source Location | Created |
|---|---|---|
| State Bill Page | https://www.congress.gov/bill/116th-congress/house-bill/3223/all-info | 06/14/2019 |
| BillText | https://www.congress.gov/116/bills/hr3223/BILLS-116hr3223ih.pdf | 06/16/2019 |
| Bill | https://www.congress.gov/116/bills/hr3223/BILLS-116hr3223ih.pdf.pdf | 06/16/2019 |
Loading...